Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000133

Chief Operations Officer acquired 13,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Johnston Lloyd P. Chief Operations Officer 2021-10-01 Grant or award +13,750 101,227 D
Loading xslF345X03/wf-form4_163346554315584.xml…